Intestinal Research

Search: Intest Res Search

CLOSE

Intestinal Research

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).

The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Statement

January 31, 2023

Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases

Han Hee Lee, Jin Su Kim, Hyeon Jeong Goong, et al.

Intest Res. 2023;21(1):3-19.

The introduction of device-assisted enteroscopy (DAE) in the beginning of 21st century has revolutionized the diagnosis and treatment of diseases of the small intestine. In contrast to capsule endoscopy, the...

Review

January 31, 2023

Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition

Su Young Kim, Min Seob Kwak, Soon Man Yoon, et al.

Intest Res. 2023;21(1):20-42.

Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance...

Review

October 18, 2022

Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease

Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, et al.

Intest Res. 2023;21(1):43-60.

Crohn’s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various...

Review

May 31, 2022

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis

Soo-Young Na, Chang Hwan Choi, Eun Mi Song, et al.

Intest Res. 2023;21(1):61-87.

Ulcerative colitis (UC), a relapsing-remitting chronic inflammatory bowel disease (IBD), has a variable natural course but potentially severe disease course. Since the development of anti-tumor necrosis factor (TNF) agents has...

Original Article

March 11, 2022

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis

Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, et al.

Intest Res. 2023;21(1):88-99.

Background/Aims: Patients with ulcerative colitis (UC) are at an increased risk of certain infections and malignancies compared with the general population. Incidence rates (IRs) of hospitalized infections, herpes zoster (HZ),...

Original Article

November 14, 2022

Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice

Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, et al.

Intest Res. 2023;21(1):100-109.

Background/Aims: Exacerbating factors of ulcerative colitis (UC) are multiple and complex with individual influence. We aimed to evaluate the efficacy of disease control by searching and restricting inflammation trigger factors...

Original Article

March 11, 2022

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial

Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, et al.

Intest Res. 2023;21(1):110-125.

Background/Aims: The safety and efficacy of filgotinib, a once-daily oral Janus kinase 1 preferential inhibitor, were evaluated in Japanese patients with ulcerative colitis (UC) in the phase 2b/3 SELECTION trial. Methods:...

Original Article

July 22, 2022

Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis

Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, et al.

Intest Res. 2023;21(1):126-136.

Background/Aims: The usefulness of ultrasonography (US) in diseases of the gastrointestinal tract has been reported recently. This prospective study aimed to determine the features of US findings in immune-mediated colitis...

Original Article

July 12, 2022

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study

Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, et al.

Intest Res. 2023;21(1):137-147.

Background/Aims: We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD). Methods: CD patients who started UST were prospectively enrolled from 4...

Original Article

June 14, 2022

Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease

Seung Yong Shin, Young Kim, Won-Seok Kim, et al.

Intest Res. 2023;21(1):148-160.

Background/Aims: The fecal microbiota of Korean patients with inflammatory bowel disease (IBD) was investigated with respect to disease phenotypes and taxonomic biomarkers for diagnosis and prognosis of IBD. Methods: Fecal samples...

Current Issue: Volume 21(1); Jan 2023

This archive contains links to the full-text of all issues of Intest Res.

All issues

Vol. 21
2023

v.21(1)
Jan 2023

Vol. 20
2022

v.20(1)
Jan 2022

v.20(2)
Apr 2022

v.20(3)
Jul 2022

v.20(4)
Oct 2022

Vol. 19
2021

v.19(1)
Jan 2021

v.19(2)
Apr 2021

v.19(3)
Jul 2021

v.19(4)
Oct 2021

Vol. 18
2020

v.18(1)
Jan 2020

v.18(2)
Apr 2020

v.18(3)
Jul 2020

v.18(4)
Oct 2020

Vol. 17
2019

v.17(1)
Jan 2019

v.17(2)
Apr 2019

v.17(3)
Jul 2019

v.17(4)
Oct 2019

Vol. 16
2018

v.16(1)
Jan 2018

v.16(2)
Apr 2018

v.16(3)
Jul 2018

v.16(4)
Oct 2018

Vol. 15
2017

v.15(1)
Jan 2017

v.15(2)
Apr 2017

v.15(3)
Jul 2017

v.15(4)
Oct 2017

Vol. 14
2016

v.14(1)
Jan 2016

v.14(2)
Apr 2016

v.14(3)
Jul 2016

v.14(4)
Oct 2016

Vol. 13
2015

v.13(1)
Jan 2015

v.13(2)
Apr 2015

v.13(3)
Jul 2015

v.13(4)
Oct 2015

Vol. 12
2014

v.12(1)
Jan 2014

v.12(2)
Apr 2014

v.12(3)
Jul 2014

v.12(4)
Oct 2014

Vol. 11
2013

v.11(1)
Jan 2013

v.11(2)
Apr 2013

v.11(3)
Jul 2013

v.11(4)
Oct 2013

Vol. 10
2012

v.10(1)
Feb 2012

v.10(2)
Apr 2012

v.10(3)
Jul 2012

v.10(4)
Oct 2012

Vol. 9
2011

v.9(1)
Apr 2011

v.9(2)
Aug 2011

v.9(3)
Dec 2011

Vol. 8
2010

v.8(1)
Jun 2010

v.8(2)
Dec 2010

Vol. 7
2009

v.7(1)
Jun 2009

v.7(2)
Dec 2009

Vol. 6
2008

v.6(1)
Jun 2008

v.6(2)
Dec 2008

Vol. 5
2007

v.5(1)
Jun 2007

v.5(2)
Dec 2007

Vol. 4
2006

v.4(1)
Jun 2006

v.4(2)
Dec 2006

Vol. 3
2005

v.3(1)
Jun 2005

v.3(2)
Dec 2005

Vol. 2
2004

v.2(1)
Apr 2004

v.2(2)
Dec 2004

Vol. 1
2003

v.1(1)
May 2003

v.1(2)
Nov 2003

ARTICLE & TOPICS

Article Category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

EDITORIAL POLICY

AUTHOR INFORMATION

Editorial Office: Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

prev

next

prev

next